Cunha, Lídia Alexandra dos Santos2024-05-212024-05-212013http://hdl.handle.net/10400.22/25541Documento Técnico submetido para suporte à Candidatura ao Título de Especialista no Grupo 7 – Saúde e Protecção Social / Área de Estudo 72 – Saúde / Área de Educação e Formação 725 – Tecnologias de Diagnóstico e Terapêutica / Medicina NuclearDrug development represents a highly complex, inefficient and costly process. Over the last decade, the widespread use of nuclear imaging, due to its functional and molecular nature, has proven to be determinant in improving the efficiency on selecting the candidate drugs that should be abandoned or move forward to clinical. This reflects not only into the development of safer and effective drugs, but also the shortening of time-to-market. The modern concept and future trends concerning molecular imaging is assumedly hybrid or multimodality imaging, including combinations between high sensitivity and functional (molecular) modalities with high spatial resolution and morphological techniquesengDrug developmentMolecular imagingNuclear imagingPET/SPECT biomarkersRadiochemistryreport